Disposition of oral clarithromycin in foals

Authors

  • S. Jacks,

    1. Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
    Search for more papers by this author
  • S. Gigue`re,

    Corresponding author
    1. Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
      S. Giguère, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, PO Box 100136, 2016 SW 16th Ave., Gainesville, FL 32610, USA. E-mail: gigueres@mail.vetmed.ufl.edu
    Search for more papers by this author
  • R. R. Gronwall,

    1. Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
    Search for more papers by this author
  • M. P. Brown,

    1. Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
    Search for more papers by this author
  • K. A. Merritt

    1. Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
    Search for more papers by this author

S. Giguère, Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, PO Box 100136, 2016 SW 16th Ave., Gainesville, FL 32610, USA. E-mail: gigueres@mail.vetmed.ufl.edu

Abstract

Clarithromycin offers numerous advantages over erythromycin and thus, is an attractive alternative for the treatment of Rhodococcus equi infections in foals. The disposition of clarithromycin was investigated in 6 foals after intragastric administration at a dose of 10 mg/kg body weight. Detectable serum concentrations of clarithromycin were found in 3 of 6 foals at 10 minutes and in all foals by 20 minutes post-administration. Time to peak serum concentration (Tmax) was 1.5 hours and peak serum concentration (Cmax) was 0.92±0.17 μg/ml. Mean serum concentrations decreased to 0.03 μg/ml at 24 h. No adverse reactions were noted during or after IG administration in any of the foals. Based on the pharmacokinetic parameters, the MIC90 of R. equi isolates, and predicted steady state concentrations, an oral dose of 7.5 mg/kg given every 12 hours would appear appropriate for the treatment of R. equi infections in foals.

Ancillary